NCT02512926 2025-10-15
POE14-01
Stanford University
Phase 1 Completed
Clinical Trials
3 trialsNCT03530683 2024-09-03
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma
Pfizer
Phase 1 Terminated
NCT01137747 2016-06-14
AML ALL
Washington University School of Medicine
Phase 1 Completed